A retrospective study characterizing morphologic changes in the tumor and nontumor liver tissue from patients who underwent partial or total hepatectomy following nivolumab therapy for hepatocellular carcinoma
Latest Information Update: 01 Dec 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Dec 2021 New trial record